- Home
- ARRY vs GHRS Comparison
ARRY vs GHRS Comparison
Compare ARRY & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARRY
- GHRS
- Stock Information
- Founded
- ARRY 1989
- GHRS 2018
- Country
- ARRY United States
- GHRS Ireland
- Employees
- ARRY N/A
- GHRS N/A
- Industry
- ARRY Semiconductors
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- ARRY Technology
- GHRS Health Care
- Exchange
- ARRY Nasdaq
- GHRS Nasdaq
- Market Cap
- ARRY 785.6M
- GHRS 849.8M
- IPO Year
- ARRY 2020
- GHRS 2021
- Fundamental
- Price
- ARRY $7.40
- GHRS $12.31
- Analyst Decision
- ARRY Buy
- GHRS Strong Buy
- Analyst Count
- ARRY 20
- GHRS 8
- Target Price
- ARRY $9.47
- GHRS $30.63
- AVG Volume (30 Days)
- ARRY 5.4M
- GHRS 187.6K
- Earning Date
- ARRY 08-07-2025
- GHRS 05-08-2025
- Dividend Yield
- ARRY N/A
- GHRS N/A
- EPS Growth
- ARRY N/A
- GHRS N/A
- EPS
- ARRY N/A
- GHRS N/A
- Revenue
- ARRY $1,064,767,000.00
- GHRS N/A
- Revenue This Year
- ARRY $23.50
- GHRS N/A
- Revenue Next Year
- ARRY $11.23
- GHRS N/A
- P/E Ratio
- ARRY N/A
- GHRS N/A
- Revenue Growth
- ARRY N/A
- GHRS N/A
- 52 Week Low
- ARRY $3.76
- GHRS $6.00
- 52 Week High
- ARRY $12.62
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- ARRY 54.53
- GHRS 52.37
- Support Level
- ARRY $6.64
- GHRS $12.43
- Resistance Level
- ARRY $8.09
- GHRS $13.15
- Average True Range (ATR)
- ARRY 0.59
- GHRS 0.99
- MACD
- ARRY -0.05
- GHRS -0.14
- Stochastic Oscillator
- ARRY 55.87
- GHRS 41.03
About ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.